Astrazeneca (AZN) Net Income Attributable to Noncontrolling Interests (2009 - 2026)
Astrazeneca's Net Income Attributable to Noncontrolling Interests was -$1 million in Q3 2026, compared with $2 million a year earlier.
Powered by 
Analysis
Astrazeneca (AZN) Net Income Attributable to Noncontrolling Interests (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Astrazeneca's Net Income Attributable to Noncontrolling Interests was $4 million through Sep 30, 2026, unchanged year-over-year; for FY2025, it was $8 million, up 33.3% from FY2024.
- In earlier years, Net Income Attributable to Noncontrolling Interests was $6 million in FY2024 (unchanged), $6 million in FY2023 (+20.0%), $5 million in FY2022 (+66.7%) and $3 million in FY2021.
- The Q3 2026 figure marks the lowest quarterly Net Income Attributable to Noncontrolling Interests since Q2 2025.
- The best year-over-year quarter for Net Income Attributable to Noncontrolling Interests over five years was Q1 2025 (growth of 400.0%); the worst was Q1 2026 (a decline of 80.0%).
- Per Business Quant data, AZN's Net Income Attributable to Noncontrolling Interests in the three quarters before Q3 2026 was $1 million (Q2 2026), $1 million (Q1 2026) and $3 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | - |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1.00 Mn |
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | -2.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | -1.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | -372.00 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
API Access
Astrazeneca Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();